Turning Point Therapeutics (TPTX) Stock Forecast for 2024–2028. Sell or Buy Prediction
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for TPTX stock
Turning Point Therapeutics, Inc. Analysis
TPTX Stock News


Popular stocks:
Suncor Energy
Square
Amazon
Energy Transfer
Etsy
Micron

TOP Stocks:
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
PagSeguro Digital
Post Holdings Partnering
Energy Services of America
Alfi
Stryker
Sports Entertainment Acquisition
GameStop
Digital World Acquisition
Netflix
Adobe


Financial News

Popular Stocks Analysis

Helpful Highlights
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
  1. Home
    2. »
  2. Stock forecasts
    3. »
  3. TPTX

Turning Point Therapeutics (TPTX) Stock Forecast for 2024–2028. Sell or Buy?

Updated: March 18, 2024 (10:07)

Sector: Healthcare

The share price of Turning Point Therapeutics, Inc. (TPTX) now

This company is DELISTED
Latest session on the 8th of September for
Turning Point Therapeutics, Inc. is negative
Trading Volume: 4322
Open: 76.01 /  High: 76.01 /  Low: 76.01
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Turning Point Therapeutics stocks, the 50-day moving average is the support level today.

For Turning Point Therapeutics stocks, the 200-day moving average is the support level today.

Are you interested in Turning Point Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Turning Point Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Turning Point Therapeutics share be worth in 2024 - 2028?

When should I take profit in Turning Point Therapeutics stock? When should I record a loss on Turning Point Therapeutics stock? What are analysts' forecasts for Turning Point Therapeutics stock? What is the future of Turning Point Therapeutics stock? We forecast Turning Point Therapeutics stock performance using neural networks based on historical data on Turning Point Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Turning Point Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Turning Point Therapeutics shares. This happens once a day.


Historical and forecast chart of Turning Point Therapeutics stock

The chart below shows the historical price of Turning Point Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Turning Point Therapeutics stock price can be found in the table below.

No data

Long-term forecasts by years.

Turning Point Therapeutics, Inc., a clinical stage biopharmaceutical company, designs and develops new small molecule targeted cancer therapies. He is developing a suite of tyrosine kinase inhibitors (TKIs) that targets cancer genetic factors in previously TKI-naive and TKI-treated patients.

Turning Point Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 16 80.75 78.57 84.14 7.09
Dec 17 82.40 79.33 85.51 7.79
Dec 18 77.70 76.77 80.59 4.98
Dec 19 78.68 77.31 80.48 4.09
Dec 20 79.77 76.99 81.20 5.47
Dec 21 79.34 77.48 80.77 4.24
Dec 22 78.77 75.79 82.45 8.79
Dec 23 78.81 77.58 80.28 3.47
Dec 24 80.18 76.38 83.31 9.07
Dec 25 78.69 75.29 82.14 9.09
Dec 26 76.19 75.28 78.71 4.55
Dec 27 78.48 76.64 81.16 5.90
Dec 28 78.67 75.74 82.44 8.85
Dec 29 82.77 80.24 85.35 6.38
Dec 30 87.19 84.63 90.17 6.55
Dec 31 85.88 82.64 87.27 5.61
Jan 01 89.65 88.57 92.44 4.37
Jan 02 90.40 88.17 92.51 4.92
Jan 03 85.95 82.96 87.86 5.91
Jan 04 82.24 79.28 84.56 6.66
Jan 05 82.83 79.75 86.46 8.41
Jan 06 81.89 79.18 85.42 7.88
Jan 07 82.87 80.43 84.91 5.56
Jan 08 85.85 82.35 88.07 6.94
Jan 09 86.57 82.94 88.39 6.58
Jan 10 90.47 87.43 92.97 6.33
Jan 11 91.66 87.70 95.46 8.84
Jan 12 91.83 88.36 95.96 8.61
Jan 13 91.55 89.74 94.19 4.96
Jan 14 93.86 90.93 97.63 7.37

Turning Point Therapeutics Daily Price Targets


Turning Point Therapeutics Stock Forecast 12-16-2023.

Forecast target price for 12-16-2023: $80.75.
Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 6.622%.
Pessimistic target level: 78.57
Optimistic target level: 84.14

Turning Point Therapeutics Stock Forecast 12-17-2023.

Forecast target price for 12-17-2023: $82.40.
Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 7.227%.
Pessimistic target level: 79.33
Optimistic target level: 85.51

Turning Point Therapeutics Stock Forecast 12-18-2023.

Forecast target price for 12-18-2023: $77.70.
Negative dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 4.744%.
Pessimistic target level: 76.77
Optimistic target level: 80.59

Turning Point Therapeutics Stock Forecast 12-19-2023.

Forecast target price for 12-19-2023: $78.68.
Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 3.930%.
Pessimistic target level: 77.31
Optimistic target level: 80.48

Turning Point Therapeutics Stock Forecast 12-20-2023.

Forecast target price for 12-20-2023: $79.77.
Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 5.187%.
Pessimistic target level: 76.99
Optimistic target level: 81.20

Turning Point Therapeutics Stock Forecast 12-21-2023.

Forecast target price for 12-21-2023: $79.34.
Negative dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 4.067%.
Pessimistic target level: 77.48
Optimistic target level: 80.77

TPTX (TPTX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
May. 85.21 74.15 99.64 25.59
Jun. 84.46 73.31 93.93 21.96
Jul. 90.59 85.21 94.77 10.09
Aug. 89.39 80.15 101.78 21.25
Sep. 97.65 83.04 113.98 27.14
Oct. 112.48 104.06 127.57 18.43
Nov. 111.98 94.00 123.81 24.08
Dec. 111.49 99.72 129.64 23.08
Full forecast for 2024

Turning Point Therapeutics forecast for this year


Turning Point Therapeutics Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $85.2072. Pessimistic: $74.15. Optimistic: $99.64


Turning Point Therapeutics Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $84.4574. Pessimistic: $73.31. Optimistic: $93.93


Turning Point Therapeutics Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $90.589. Pessimistic: $85.21. Optimistic: $94.77


Turning Point Therapeutics Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $89.3932. Pessimistic: $80.15. Optimistic: $101.78


Turning Point Therapeutics Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $97.6532. Pessimistic: $83.04. Optimistic: $113.98


Turning Point Therapeutics Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $112.477. Pessimistic: $104.06. Optimistic: $127.57


Turning Point Therapeutics Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $111.982. Pessimistic: $94.00. Optimistic: $123.81


Turning Point Therapeutics Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $111.489. Pessimistic: $99.72. Optimistic: $129.64



Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 111.74 104.61 125.75 16.81
Feb 124.52 105.34 145.88 27.79
Mar 115.75 107.35 121.35 11.54
Apr 114.73 101.86 128.62 20.80
May 120.79 112.29 139.13 19.29
Jun 135.67 121.94 152.39 19.98
Jul 148.21 126.69 159.95 20.79
Aug 152.77 131.93 163.19 19.15
Sep 173.95 164.00 194.23 15.57
Oct 189.25 171.35 198.41 13.64
Nov 184.26 170.48 204.93 16.81
Dec 172.10 161.87 194.44 16.75
Full forecast for 2025

Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 189.89 173.18 222.48 22.16
Feb 209.94 195.63 223.80 12.59
Mar 210.87 180.25 246.13 26.76
Apr 231.74 214.41 259.28 17.30
May 232.25 205.17 271.60 24.46
Jun 217.95 199.25 253.43 21.38
Jul 219.39 184.64 231.45 20.23
Aug 176.91 147.72 200.65 26.38
Sep 193.65 180.02 215.38 16.42
Oct 167.66 154.75 185.00 16.35
Nov 141.84 134.04 151.20 11.35
Dec 159.63 142.07 178.24 20.29
Full forecast for 2026

Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 180.00 162.18 191.08 15.13
Feb 206.53 191.99 221.52 13.33
Mar 199.26 189.18 231.70 18.35
Apr 181.72 171.73 205.31 16.36
May 162.13 144.66 176.40 18.00
Jun 197.80 175.61 209.55 16.20
Jul 202.15 174.14 227.95 23.61
Aug 184.81 157.98 203.11 22.22
Sep 190.91 163.19 208.13 21.59
Oct 196.37 165.26 221.86 25.51
Nov 210.63 194.87 225.45 13.57
Dec 192.55 181.96 202.72 10.24
Full forecast for 2027

Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 223.48 187.10 258.38 27.59
Feb 255.93 237.91 293.09 18.83
Mar 287.46 255.20 307.69 17.06
Apr 255.84 219.25 299.17 26.71
May 259.21 227.85 295.71 22.95
Jun 238.68 210.85 257.59 18.14
Jul 231.86 217.57 262.97 17.26
Aug 186.97 156.12 215.35 27.50
Sep 182.45 173.21 211.75 18.20
Oct 189.27 170.53 221.33 22.95
Nov 176.36 154.63 194.21 20.38
Dec 193.82 168.24 216.42 22.26
Full forecast for 2028

Turning Point Therapeutics information and performance

Turning Point Therapeutics Address

N/A

Market Capitalization: N/A $

Market capitalization of the Turning Point Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of TPTX shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Turning Point Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector

Petros Pharmaceuticals, Inc. (PTPI)
Ardelyx, Inc. (ARDX)
Moderna, Inc. (MRNA)
NLS Pharmaceutics AG (NLSP)
Immix Biopharma, Inc. (IMMX)
Merck & Co., Inc. (MRK)
Calliditas Therapeutics AB (publ) (CALT)
Clever Leaves Holdings Inc. (CLVR)
Inspira Technologies Oxy B.H.N. Ltd. (IINN)
Trevi Therapeutics, Inc. (TRVI)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.


This website uses cookies to ensure you get the best experience on our website